Updated: May 19, 2026

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
Published on: April 15, 2022
Ling Zheng1, Zhiyong Zeng, Junfang Lin
1Department of Hematology and Rheumatology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, P.R. China.
IgM Multiple Myeloma (MM) is rare and aggressive. Distinguishing it from Waldenstrom
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: